UKCA Marking of Medical Devices – An update on the status quo

Dr Hanna Gul
An update on UKCA Marking of Medical Devices

UKCA (United Kingdom Conformity Assessed) marking of medical devices was due to become mandatory in July 2023, placing medical device manufacturers under real pressure to ensure they were in alignment with UK requirements.

However, due to delays in processing applications and introducing the new medical device regulatory framework, the MHRA have just announced that they will be extending the UKCA implementation deadline to July 2024. This comes as a welcome relief to medical device manufacturers, who now have more time to ensure that they are adequately prepared for this transition.

The availability of more time is not a reason to put UKCA to the back of collective minds however. Rather, it’s an opportunity to take stock and ensure that a UKCA strategy is properly developed and implemented well before the new deadline.

In this article, we review updated requirements for UKCA marking and what they mean for manufacturers.

What is a UKCA mark?

Following Great Britain’s exit from the EU single market in December 2020, CE (Conformité Européenne) marking was to be replaced by the UKCA mark for medical devices marketed in the territory. The UKCA mark is a mandatory mark on a product which indicates that it conforms to the new GB legislation and operates in much the same way as a CE mark in Europe.

The manufacturer or, if mandated, their authorised representative is responsible for affixing a UKCA mark to the product, assuming they are authorised to do so following a conformity process.

Where will it apply?

The UKCA mark only applies in Great Britain (England, Scotland and Wales). CE marking will continue in Northern Ireland (NI) as it remains aligned with the EU single market for goods. Products that will be placed on the market in both GB and NI will therefore need both UKCA and CE marking unless they are “Qualifying Northern Ireland Goods”, in which case they can be sold in GB with a CE mark and do not need a UKCA mark.

Are there any differences between UKCA and CE marking?

As of today, two different legal frameworks exist to obtain UKCA/CE marking for a product, dependent on whether it is marketed in the UK or the EU, respectively. In the UK, the regulations are based on the old Medical Device Directive (MDD), implemented into domestic law by the UK Medical Device Regulations 2002 (UK MDR 2002). Prior to the end of the transition period, this gave effect in UK law to the following Directives:

Because the Brexit transition period ended before the European Medical Device Regulation (EU) 2017/745 came into effect, the European MDR has not been adopted in the UK, unlike in Europe where it is now mandatory to comply with MDR 2017/745 to obtain a medical device CE mark. This means that the Great Britain route to market and UKCA marking requirements are still officially based on the requirements in the MDD.

Moving forwards, this means in principle that companies will need two parallel frameworks to be able to market products in both the UK and EU, hence the need for a transition period. The extended transition period outlined by the MHRA will hopefully lessen the burden of becoming compliant with both systems.

Can a product have both UKCA and CE marks?

Providing a product fulfils the necessary requirements, it may carry both a UKCA and CE mark. The presence of multiple conformity marks is common on internationally sold products.

What UK legislation needs to be followed?

The UK government has issued several Statutory Instruments to amend current legislation, including The Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019 and has now concluded consultation on the UK MDR 2022. The specific details of the new UK medical device framework are yet to be published following the UK government consultation on the proposed changes, which started in 2021. However, the government response in June 2022 highlighted that the new GB medical device regulations will be closely aligned with the 2017 EU Medical Device Regulations.

When will UKCA marking come into force?

As previously stated, UKCA marking was due to be enforced from July 2023, in-line with the UK Medical Device Regulations 2022 (UK MDR 2022). However, due to understandable delays with regard to publishing the new regulatory framework and the backlog of applications submitted to notified bodies, the MHRA issued a statement on 21st October 2022 indicating that this will be delayed until July 2024. Since this has not yet been confirmed by law, further updates are expected from the MHRA and will be announced via the MHRA website in the near future. The UK MDR 2022 will also be updated to reflect these changes.

It is important to highlight that current and valid CE marks will continue to be accepted in Great Britain until this time point. New legislation on medical device regulation highlighting the transitional arrangements is due to be released by the government in Spring 2023. This will also include new Post-Market Surveillance requirements.

Manufacturers will be able to continue to place CE marked devices on the GB market after 1 July 2023. From July 2024, the transitional arrangements will apply for CE and UKCA marked devices placed on the GB market. Where third party conformity assessment is required, a UK Approved Body is needed. However, manufacturers of non-sterile and non-measuring Class I devices and general IVDs can self-certify against the UKCA marking.

The government’s June 2022 response has indicated that there will be generous transitional periods in the new medical device framework. These arrangements would allow products to be placed on the market as follows:

  1. General medical devices - until either the certificate expires or for three years after the new regulations take effect (whichever occurred sooner) and
  2. In-vitro Diagnostics (IVDs) - until either the certificate expires or five years after the new regulations take effect (whichever is sooner)

Transitional provisions would not apply if there were significant changes in the design or intended purpose of the device. Furthermore, all products that will benefit from transitional arrangements will need to comply with post-market requirements. The below schematic illustrates the updated timeline for UKCA marking.

Updated UKCA timline

  • January 2021

    UKCA marking comes into force.

  • January 2021 to June 2024

    Medical devices & IVD devices can be either CE or UKCA marked (or both).

  • 30th June 2024

    Deadline for medical device & IVD device manufacturers to replace existing CE marks with UKCA mark.

  • 1st July 2024

    UKCA mark will be mandatory for all medical devices & IVD devices on the GB market. CE marking will not be recognised.

Note: Current timeline in-line with the MHRA update on 21st October 2022 (maybe subject to change)

What needs immediate action?

To ensure that manufacturers are prepared for a smooth transition, in-line with the new timescales for UKCA marking, the following are key requirements for placing a device on the GB market:

  • All medical devices, including in-vitro diagnostic medical devices (IVDs), custom-made devices and systems or procedure packs, need to be registered with the MHRA before they are placed on the Great Britain market
  • If you are a medical device manufacturer based outside the UK and wish to place a device on the GB market, you need to appoint a single UK Responsible Person for all of your devices, who will act on your behalf to carry out specified tasks, such as registration.
  • CE marking will continue to be recognised in Great Britain until 30 June 2024
  • Certificates issued by EU-recognised Notified Bodies will continue to be valid for the GB market until 30 June 2024
  • The EU no longer recognises UK Notified Bodies
  • UK Notified Bodies are not able to issue CE certificates - and have become UK Approved Bodies

The bottom line

The bottom line is – don’t panic! The delay in enforcing UKCA marking is a great opportunity to prepare and re-assess your regulatory strategy so that you are ahead of the game of other competitors in the field. Investing time to get things correct, in-line with new regulations will ensure that your medical devices can continue to be sold and used where they are required most, ultimately leading to improved health outcomes.

If you require further information you may wish to visit the ‘Useful resources’ section below.

If you have any concerns about your regulatory strategy that have been brought up in this article, you can email us or call +44(0)114 299 2599 to speak directly with our experienced team. We promise: no phone menus, no waiting, no obligation and complete confidence.

Related articles

  1. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  2. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  3. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  4. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  5. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  6. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Lead Medical Writer
  7. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  8. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Lead Medical Writer
  9. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  10. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  11. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  12. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  13. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  14. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  15. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  16. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  17. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  18. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  19. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  20. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  21. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  23. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  25. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  26. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  27. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  28. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need help with your regulatory strategy?

Talk to us